Skip to main content

Table 2 Seroprevalence to four malarial antigens by age group

From: Using serological measures to monitor changes in malaria transmission in Vanuatu

Location

Age group (years)

N Pf MSP

Pf MSP +ve

% Pf MSP +ve

N Pf AMA

Pf AMA +ve

% Pf AMA +ve

N Pf SE

Pf SE +ve

% PfSE +ve

N Pv MSP

Pv MSP +ve

% Pv MSP +ve

N Pv AMA

Pv AMA +ve

% Pv AMA+ve

 

0-5

64

4

6.3 (1.6-12.3)

65

7

10.8 (3.0-18.5)

66

5

7.6 (1.0-14.1)

66

13

19.7 (9.8-29.5)

65

8

12.3 (4.1-20.5)

Northern Tanna

5-20

176

15

8.5 (4.4-12.7)

174

29

16.7 (11.1-22.3)

176

25

14.2 (9.0-19.4)

172

27

15.7 (10.2-21.2)

175

20

11.4 (6.7-16.2)

 

20-80

121

44

36.4 (27.7-45.1)

119

43

36.1 (27.4-45.0)

120

68

56.7 (47.7-65.7)

119

37

31.1 (22.7-39.5)

121

41

33.9 (25.3-42.4)

 

Total

361

63

17.5 (13.5-21.4)

358

79

22.1 (17.8-26.4)

362

98

27.1 (22.5-31.7)

357

77

21.6 (17.3-25.9)

361

69

19.1 (15.0-23.2)

 

0-5

115

3

2.6 (0-5.6)

119

5

4.2 (0.5-7.9)

119

1

0.8 (0.0-2.5)

117

6

5.1 (1.1-9.2)

119

4

3.4 (0.1-6.6)

Northern Tanna Highlands

5-20

216

13

6.0 (2.8-9.2)

218

14

6.4 (3.1-9.7)

221

12

5.4 (2.4-8.4)

216

14

6.5 (3.2-9.8)

220

15

6.8 (3.5-10.2)

 

20-80

173

21

11.6 (7.2-17.1)

174

35

20.1 (14.1-26.1)

176

66

37.9 (30.6-45.2)

174

12

6.9 (3.1-10.7)

173

22

12.7 (7.7-17.7)

 

Total

504

37

7.3 (5.1-9.6)

511

54

10.6 (7.9-13.2)

514

79

15.4 (12.2-18.5)

507

32

6.3 (4.2-8.4)

512

41

8.0 (5.6-10.4)

 

0-5

52

1

1.9 (0-5.8)

52

2

3.8 (0-9.3)

51

0

0.0

51

5

9.8 (1.4-18.3)

52

8

15.4 (5.2-25.5)

Southern Tanna

5-20

195

3

1.5 (0-3.3)

188

7

3.6 (1.0-6.2)

192

3

1.6 (0.0-3.3)

195

22

11.3 (6.8-15.8)

194

31

16.0 (10.8-21.2)

 

20-80

123

12

9.8 (4.4-15.1)

122

11

9.0 (3.9-14.2)

121

26

21.5 (14.1-28.9)

123

19

15.5 (9.0-21.9)

122

37

30.3 (22.1-38.6)

 

Total

370

16

4.3 (2.2-6.4)

349

20

5.4 (3.1-7.7)

364

29

8.0 (5.2-10.8)

369

46

12.5 (9.1-15.9)

368

76

20.7 (16.5-24.8)

 

0-5

90

1

1.1 (0-3.3)

90

4

4.4 (0.1-8.8)

90

4

4.4 (0.1-8.7)

90

3

3.3 (0-7.1)

88

3

3.4 (0-7.3)

Aneityum

5-20

218

9

4.1 (1.5-6.8)

218

10

4.6 (1.8-7.4)

219

5

2.3 (0.3-4.3)

219

9

4.1 (1.5-6.8)

210

12

5.7 (2.6-8.9)

 

20-80

208

24

11.5 (7.2-15.9)

208

16

7.7 (4.0-11.1)

208

52

25 (19.1-30.9)

208

20

9.6 (5.6-13.7)

207

36

17.4 (12.2-22.6)

 

Total

516

34

6.6 (4.4-8.7)

516

30

5.8 (3.8-7.8)

517

61

11.8 (9.0-14.6)

517

32

6.2 (4.1-8.3)

505

51

10.1 (7.5-12.7)

  1. Number of positive individuals and seroprevalence (95% CIs) to PfMSP-119, PfAMA, PfSE, PvMSP-119 and PvAMA for three age groups in three settlements on Tanna and two settlements combined on Aneityum